Business Segments · Cost of Sales
Developed Markets Segment — Cost of Sales
Viatris Developed Markets Segment — Cost of Sales decreased by 7.3% to $1.01B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.3%, from $926.20M to $1.01B. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2024
Last reportedQ1 2026
How to read this metric
An increase relative to sales suggests margin compression due to rising production costs or unfavorable product mix.
Detailed definition
The direct costs associated with producing and delivering the pharmaceutical products sold within the developed markets...
Peer comparison
Standard 'Cost of Goods Sold' (COGS) reported at the segment level for manufacturing firms.
Metric ID:
vtrs_segment_developed_markets_segment_cost_of_salesHistorical Data
7 periods
| Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $976.40M | $1.03B | $1.02B | $926.20M | $1.00B | $1.09B | $1.01B |
| QoQ Change | — | +5.0% | -0.7% | -9.0% | +8.5% | +8.7% | -7.3% |
| YoY Change | — | — | — | -5.1% | -2.0% | +7.3% | +9.3% |
Range$926.20M – $1.09B
CAGR+2.4%
Avg YoY Growth+2.4%
Median YoY Growth+2.7%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Viatris's developed markets segment — cost of sales?
- Viatris (VTRS) reported developed markets segment — cost of sales of $1.01B in Q1 2026.
- How has Viatris's developed markets segment — cost of sales changed year-over-year?
- Viatris's developed markets segment — cost of sales increased by 9.3% year-over-year, from $926.20M to $1.01B.
- What does developed markets segment — cost of sales mean?
- The direct costs incurred to manufacture and supply products for this segment.